13
Views
1
CrossRef citations to date
0
Altmetric
Articles

Sera from Lupus Patients Inhibit Growth of P. Falciparum in Culture

, , , &
Pages 253-263 | Received 11 Apr 2000, Published online: 31 May 2017

References

  • Christian CL, Elkon KB. Autoantibodies to intracellular pro-teins: clinical and biological significance. Am. J. Med. 1986: 80: 53–61.
  • Kotzin BL. Systemic Lupus Erythematosus. Cell. 1996: 85: 303-306.
  • Nakamura RM, Peebles CL, Rubin RL, Molden DP, Tan EM. Diversity of autoantibodies to nuclear antigens. In Autoanti-bodies to Nuclear Antigens (ANA): Advances in laboratory tests and significance in systemic rheumatic disease. Ameri-can Society of Clinical Pathologists Press, Chicago. 1985: 7-12.
  • Tan EM, Cohen AS, Fries IF. The 1982 revised criteria for the classification of SLE. Arthritis Rheum. 1982: 25: 1271–1277.
  • Elkon K, Skelly S, Parnassa A, Moller W, Danho W, Weissbach H, Brot N. Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc. Natl. Acad Sci. USA. 1986: 83: 7419–7423.
  • Rich BE, Steiz IA. Human acidic ribosomal phosphoproteins PO, P1 and P2: Analysis of cDNA clones, in vimosynthesis and assembly. MoL Cell. Biol. 1987: 7: 4065–4074.
  • Elkon K, Bonfa E, Llovet R, Danho W, Weissbach H, Brot N. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc. Natl. Acad Sci. USA, 1988: 85:5186–5189.
  • Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weisbach H, Brot N, Elkon K. Association between lupus psychosis and anti-ribosomal P protein antibodies. N. Eng. J. Med. 1987: 317: 265–271.
  • Schneebaum AB, Singleton JD, West SG, Blodgett JK, Alley LG, Cheronis JC, Kotzin BL. Association of psychiatric manifestations with antibodies to ribosomal P proteins in sys-temic lupus erythematosus. Am. J. Med. 1991: 90: 54–62.
  • Francoeur A-M, Peebles CL, Heckman KJ, Lee JC, Tan EM. Identification of ribosomal protein autoantigens. J. Immunol. 1985: 135: 2378–2384.
  • Lobo CA, Kar SK, Ravindran B, Kabilan L, Sharma S. Novel proteins of Plasmodium falciparum identified by differential immunoscreening using immune and patient sera. Infect. Immun. 1994: 62: 651–656.
  • Chatterjee S, Singh S, Sohoni R, ICattige V, Deshpande C, Chiplunkar S, Kumar N, Sharma S. Characterization of domains of the phosphoriboprotein PO of Plasmodium falci-parum. MoL Biochem. Parasitol. 2000: 107: 143–154.
  • Soto M, Raquena JM, Quijada L, Guzman F, Patarroyo ME, Alonso C. Identification of the Leishmania infantum PO ribosomal protein epitope in canine visceral leishmaniasis. Immunol. Len. 1995: 48: 23–28.
  • Schijman AG, Levitus G, Levin MJ. Characterization of the C-termnal region of a Trypanozoma cruzi 38-1cDa ribosomal PO protein that does not react with Lupus anti-P autoantibod-ies. Immunol. Len. 1992: 33: 15–20.
  • Levin MI, Vazquez M, Kaplan D, Schijman AG. The Trypanosoma cruzi ribosomal P protein family: Classifica-tion and antigenicity. ParasitoL Today 1993: 9: 381–384.
  • Goswami A, Singh S, Redkar VD, Sharma S. 1997. Charac-terization of PO, a ribosomal phosphoprotein of Plasmodium falciparum. J. Biol. Chem. 1997: 272:12138-12143.
  • Goswami A, Chatterjee S, Sharma S. Cloning of a ribosomal phosphoprotein PO gene homologue from Plasmodium falci-parum. MoL Biochem. Parasitol. 1996: 82: 117–120.
  • Lambros C, Vanderberg JP. Synchronisation of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 1979: 65: 418–420.
  • Zuckerman A, Spira D, Hamburger J. A procedure for har-vesting of mammalian plasmodia. Bull. WHO. 1967: 37: 431–436.
  • Smith DB, Johnson KS. Single step purification of polypep-tides expressed in Escherichia colias fusions with glutath-ione-S-transferase. Gene. 1988: 67: 31–40.
  • Laemlii UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970: 227: 680–685.
  • Elkon KB, Paranassa AP, Foster CL. Lupus autoantibodies target ribosomal P proteins. ). Exp. Med. 1985: 16: 459–471.
  • Towbin H, Ramjoue HP, Kuster H, Liverani D, Gordon J. Monoclonal antibodies against eukaryotic ribosomes. Use to characterize a ribosomal protein not previously identified and antigenically related to the acidic phosphoproteins P1/P2. J. Biol. Chem, 1982: 257: 12709–12715.
  • Kaplan D, Ferrari I, Bergarni PL, Mahler E, Levitus G, Chi-ale P, Hoebeke J, Van Regenmortel MHV, Levin MI. Anti-bodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc. Natl. Acad. Sci. USA. 1997: 94: 10301–10306.
  • Santos C, Ballesta JPG. 1994. Ribosomal protein PO, con-trary to phosphoproteins PI and P2, is required for ribosome activity and Saccharomyces cerevisiae viability. J. Biol. Chem, 1994: 269: 15689–15696.
  • Koren E, Reichlin MW, Kosec M, Fugate RD, Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J. Clin. Invest. 1992: 89: 1236–1241.
  • Sun KH, Liu WT, Tang Si, Tsai CY, Hsieh SC, Wu TH, Han SH, Yu C. The expression of acidic ribosomal phosphopro-teins on the surface membrane of different tissues in autoim-mune and normal mice which are the target molecules for anti-double-stranded DNA antibodies. Immunology. 1996: 87: 362–371.
  • Yacoub A, Kelley MR, Deutsch WA. Drosophila ribosomal protein PO contains apurinic/apyrimidinic endonuclease activity. NucL Acid Res. 1996: 24: 4298–4303.
  • Derkson RHWM, Van Dam AP, Gmelig Meyling FHJ, Bijlsma JWJ, Smeenk RJT. 1990. A prospective study on anti-ribosomal P proteins in two cases of familial lupus and recurrent psychosis. Am. Rheum. Dis. 1990: 49: 779–782.
  • Teh LS, Bedwell AE, Isenberg DA, Gordon C, Emery P, Charles PJ, Harper M, Amos N, Williams BD. Antibodies to protein P in systemic lupus erythematosus. Ann Rheum. Dis. 1992: 51: 489–494.
  • Martin AL, Reichlin M. Fluctuations of antibody to ribos-omal P proteins correlate with appearance and remission of nephritis in SLE. Lupus. 1996: 5: 22–29.
  • Voller A, O’Neill P, Humphery D. Serological indices in Tan-zania. H. Antinuclear factor and malarial indices in popula-tions living at different altitudes. J. Trop. Med. Hyg. 1972: 75: 136–139.
  • Quakyi IA, Voller A, Hall AP, Johnson GD, Holborow EJ, Moody AM. Immunological abnormalities in Caucasians with malaria. Immunol. Lett. 1979: 1: 153–154.
  • Adu D, Gwyn Williams D, Quakyi IA, Voller A, Anim-Addo Y, Bruce-Tagoe AA, Johnson GD, Holborow EJ. Anti-ssDNA and antinuclear antibodies in human malarias. Clin. Exp. Immunol. 1982: 49: 310–316.
  • Boonpuclmavig S. Ekapanyakul G. Autoantibodies in sera of Thai patients with Plasmodium falciparum infection. Clin. Exp. Immunol. 1984: 58: 77–82.
  • Ribeiro DC, Ben Slama L, Gentilini M. Anti-nuclear and anti-smooth muscle antibodies in Caucasians, Africans and Asians with acute malaria. Clin. Lab. Immunol. 1991: 35: 109–112.
  • Chatterjee S, Singh S, Sohoni R, Singh NJ, Vaidya A, Long C, Sharma S. Antibodies against the ribosomal phosphopro-tein PO of Plasmodium falciparum protect mice against chal-lenge with P. yoelii Infect. Immun. 2000: 68: 4312–4318.
  • Olivera SC, Splitter GA. Immunization of mice with recom-binant L7/L I 2 ribosomal protein confers protection against Brucella abortus infection. Vaccine. 1996: 14: 959–962.
  • Fidock D, Nguyen T, Dodemont H, Wijnand M, Eling S. James A. Plasmodium falciparum ribosomal P2 protein gene expression is independent of the developmentally regulated rRNAs. Exp Parasitol 1998: 89: 125–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.